Delivery Order SPE2DB24D2013-SPE2DB26FCGRY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with a ceiling value of $1,303.59. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 27, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $3,816.15 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with completion targeted for November 3, 2025. This is a firm fixed-price delivery order issued without set-aside designation, meaning it was competitively awarded. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities, with a contract ceiling value of $11,428.44. This firm fixed-price delivery order, which utilizes non-competitive set-aside procurement, is scheduled for completion by October 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete delivery against...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml injections, with a contract ceiling value of $6,266.60. This delivery order represents a competitive, non-set-aside award utilizing firm fixed price terms and is scheduled for ultimate completion by October 24, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a ceiling value of $13,334.84. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation...
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities, with a ceiling value of $62,122.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication in 3 mL vials, with a contract ceiling value of $17,734.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $8,146.58 and an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's pharmaceutical supply services under the Defense Logistics Agency's Medical Supply Chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a contract ceiling value of $5,243.63. This firm fixed-price delivery order, which has an ultimate completion date of July 25, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award utilized no set-aside designation and was competitively awarded through...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB26FCGRYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, valued at $48,308.14 under a firm fixed-price contract. This delivery order represents a competitive award with no set-aside designation and is expected to be completed by October 31, 2025. The place of performance is identified as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The Ozempic delivery fulfills the company's role in providing specialty medications across multiple therapeutic domains as part of the DLA's pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.3k | 10/30/25 |